Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 449-360-4 | CAS number: 647828-16-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
- Oral LD50: >2500 mg/kg bw (OECD TG 423, GLP).
- Inhalation LD50: > 6500 mg/m3 (route-to-route extrapolation from acute oral toxicity study).
- Dermal LD50: >2000 mg/kg bw (OECD TG 402, GLP).
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- > 2 500 mg/kg bw
- Quality of whole database:
- The one study available is adequate for covering this endpoint.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- > 2 000 mg/kg bw
- Quality of whole database:
- The one study available is adequate for covering this endpoint.
Additional information
Acute Oral Toxicity:
In an acute oral toxicity study which was performed in accordance with the Acute Toxic Class method (OECD TG 423) and under GLP conditions, a group of three fasted female Sprague-Dawley CD strain rats were treated with the test substance at a dose level of 2000 mg/kg bw. This was followed by a further group of three fasted females at the same dose level. The test substance was administered orally undiluted. Clinical signs and body weight development were monitored during the study. All animals were subjected to gross necropsy. No mortality was observed. All animals showed expected body weight gains over the study period. There were no signs of systemic toxicity and no abnormalities were noted at necropsy. The acute oral median lethal dose (LD50) of the test material in the female Sprague-Dawley CD strain rat was estimated as being greater than 2500 mg/kg bw, based on Annex 2d of OECD TG 423.
Acute Inhalation Toxicity:
Using route to route extrapolation the inhalation toxicity can be derived as follows: an oral LD50 of 2500 mg/kg bw can be roughly converted into > 13000 mg/m3 (ECHA's CLP guidance, section, 3.1.3.3.5, 2017, using the formula: 1 mg/kg bw = 0.0052 mg/L/4h). In the present case 50/100% oral and inhalation absorption is used, which then results in an acute inhalation toxicity concentration of 6500 mg/m3. The maximum saturated vapour pressure for the substance is 41.3 mg/m3. This means that the substance cannot reach a concentration higher than 41.3 mg/m3. Therefore, an LC50 for inhalation vapour cannot be reached and no classification and labelling is needed for the acute inhalation route.
Acute Dermal Toxicity:
To assess the acute dermal toxicity of the test substance, an acute dermal toxicity study was performed in accordance with OECD TG 402 and under GLP conditions. A group of ten Sprague-Dawley CD rats (five males and five females) was given a single, 24-hour, semi-occluded dermal application of undiluted test substance to intact skin at a dose level of 2000 mg/kg bw. Clinical signs and body weight development were monitored during the study. All animals were subjected to gross necropsy. No mortality was observed. There were no signs of systemic toxicity and no dermal irritation was observed. All animals showed expected gains in body weight over the study period and no abnormalities were noted at necropsy. The acute dermal median lethal dose (LD50) of the test material In the Sprague-Dawley CD strain rat was found to be greater than 2000 mg/kg bw.
Justification for classification or non-classification
The substance does not have to be classified for acute toxicity according to EU CLP (EC No. 1272/2008 and its amendments).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.